Page 43 - Breakthrough Device News Today

BRAINBox Solutions Announces Enrollment Begins in Pivotal, HeadSMART II Clinical Study of BRAINBox TBI Concussion Diagnostic and Prognostic Test News provided by Share this article Share this article RICHMOND, Va., Dec. 16, 2020 /PRNewswire/ -- BRAINBox Solutions today announced it is beginning enrollment in its pivotal clinical trial, HeadSMART II ( Head injury Response to Trauma), of the companys concussion diagnostic and prognostic test, BRAINBox TBI. The multi-national, multi-site trial...

Share this article Share this article SAN DIEGO, Dec. 16, 2020 /PRNewswire/ -- Aethlon Medical, Inc. (Nasdaq: AEMD), a therapeutic medical device and technology company focused on unmet needs in viral diseases, oncology and inflammation, announced today that the first patient has been treated in the Companys first-in-human Early Feasibility Study (EFS) evaluating the HEMOPURIFIER® in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck. The study is enrollin...

(1) PALO ALTO, Calif., Dec. 10, 2020 /PRNewswire/ -- ReCor Medical, Inc. ("ReCor"), a wholly-owned subsidiary of Otsuka Medical Devices, announced today that its Paradise Ultrasound Renal Denervation System (the "Paradise System") demonstrated positive results in the RADIANCE-HTN TRIO ("TRIO") study, and, separately, has received Breakthrough Device Designation from the U.S. Food and Drug Administration (FDA) for the treatment of patients with uncontrolled hypertension who are inadequately resp...

Posted on 378 ReGelTec, Inc., a medical device company developing a percutaneous treatment for chronic low back pain, announced today that it has received Breakthrough Device designation from the Center for Devices and Radiological Health (CDRH) of the U.S. Food and Drug Administration (FDA). The company’s leading product is HYDRAFIL™, a patented hydrogel that is heated prior to injection into the nucleus of a degenerated disc vi...

Share this article Share this article PALO ALTO, Calif., Dec. 10, 2020 /PRNewswire/ -- ReCor Medical, Inc. ("ReCor"), a wholly-owned subsidiary of Otsuka Medical Devices, announced today that its Paradise™ Ultrasound Renal Denervation System (the "Paradise System") demonstrated positive results in the RADIANCE-HTN TRIO ("TRIO") study, and, separately, has received Breakthrough Device Designation from the U.S. Food and Drug Administration (FDA) for the treatment of patients with uncontrolled ...

Millions of online followers. three years ago she left baghdad and moved to iraqi kurdistan where she felt safer, but often returned to her native city for photo shoots and to visit her family. she is just the latest online female personality or activist to die an untimely death in iraq. and the government has launched an investigation to see if there is a link between them. her murder sparked an outburst of grief fa her followers, but not all mourned her death. one journalist with state media c...

Over 50 million people are hunched over their computers all day and there is so much more stress today. >> o.k., but, doctor, were spending $50 billion a year and nothing seems to be working. >> well, what i want to show you is a breakthrough device that i believe is going to change the way we treat back pain forever. this unique device is called the back 2 life. >> but why is this so different from all the other options we just listed that arent working so well? >> bella, let me show you. >> o....